Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Aravax Pty Ltd announces opening of IND for Phase 2 clinical trials of PVX108, a next-generation immunotherapy for the treatment of peanut allergy 2022-03-04 21:00
Genome and Company announces Clinical Trial Collaboration with MSD to evaluate 'GEN-001' in combination of KEYTRUDA® (pembrolizumab) in phase 2 clinical trial in biliary tract cancer patients 2022-03-04 09:30
InxMed Raised $50 million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers 2022-03-04 08:00
Claudin18.2 CAR T Cells (CT041) Receives Approval to Initiate A Confirmatory Phase II Clinical Trial for advanced GC/GEJ in China 2022-03-03 21:50
Akeso Announces Clinical Trial Collaboration with Chipscreen Biosciences to Evaluate Cadonilimab in Combination with Chiauranib for Extensive-Stage Small-Cell Lung Cancer 2022-03-03 01:34
Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business 2022-03-02 20:00
InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of NMOSD in China 2022-03-02 10:37
WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year 2022-03-02 10:07
Kintor Pharma Announces First Patient Dosing in Phase II Clinical Trial of KX-826 for Treatment of Androgenic Alopecia Patients in the US 2022-03-01 20:30
PHASE II CLINICAL STUDY AT WEILL CORNELL MEDICAL CENTER INVESTIGATING PAXALISIB IN COMBINATION WITH METFORMIN AND A KETOGENIC DIET ENROLLS FIRST PATIENT 2022-02-28 21:00
PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial 2022-02-25 21:00
SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer Early Detection Test 2022-02-24 21:34
Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China 2022-02-24 10:32
Foresee Pharmaceuticals and TRPharm Announce License and Co-Development Agreement 2022-02-23 23:00
BIORCHESTRA Announces 45 Million USD Series C Fundraising 2022-02-23 11:26
Gracell Biotechnologies Announces Multiple Advancements of TruUCAR Allogeneic CAR-T Platform 2022-02-22 20:30
Revotek Receives Clearance from the National Health Commission of China for the World First Clinical Trial for 3D Bioprinted Stem Cell Vascular Grafts 2022-02-21 22:30
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer 2022-02-21 22:00
Adlai Nortye Announces Publication of Preclinical Research of AN3025 (anti-hTNFR2）in Frontiers in Immunology 2022-02-21 21:00
Harbour BioMed Announces IND Approval for Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-02-21 20:29
1 126 127 128 129 130 261